Does obesity aggravate inflammation in patients with hypertension?;Czy otyłość nasila proces zapalny u chorych z nadciśnieniem tȩtniczym?

Nadcisnienie Tetnicze

Volumn 6, Issue 4, 2002, Pages 263-269

  Bogdański, Paweł ^a   Pupek Musialik, Danuta ^a   Szulińska, Monika ^a   Cymers, Maciej ^a   Bryl, Wiesław ^a   Jabłecka, Anna ^a   Ła̧cki, Jan ^a  

^a NONE

Author keywords

Atherosclerosis; Hypertension; Inflammation; Insulin resistance; Obesity

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; GLUCOSE; INSULIN; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; ATHEROGENESIS; BODY FAT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE MARKER; ENDOTHELIUM INJURY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; LIPID COMPOSITION; MALE; MECHANICAL STRESS; OBESITY;

EID: 0036966719     PISSN: 14285851     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Rywik S., Broda G., Piotrowski W. Epidemiologia chorób ukladu kra̧żenia. Program Pol-MONICA Warszawa. Kardiologia Polska 1996; 44 (supl. II): 7-35.
2. Stokes J., Kannel W., Wolf P., Cupples L., D'Agostino R. The relative importance of selected risk factors for various manifestations of cardiovascular diseases among men and women from 35 to 64 years of fallow-up in the Framingham Study. Circulation 1987; 75 (supl. V): 65-73.
3. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999; 2: 115-126.
4. Chae C., Lee R, Rifai N., Ridker P. Blood Pressure and Infiammation in Apparently Healthy Men. Hypertension 2001; 38: 399.
5. Kannel W., Brand M., Skinner J., Dewber T., Mc Nemora P. The relation of adiposity to blood pressure and development of hypertension: the Framingham study. Ann. Int. Med. 1967; 67: 48-59.
6. Larimore J. A study of blood pressure in relation to type of bodily habitus. Arch. Intern. Med. 1923; 31: 567-572.
7. Faber A. Readings of blood pressure of 1000 healthy individuals age 20-25 years. An antropometric study. Scand. Arch. Physiol. 1924; 45: 189-203.
8. Van Itallie T. The problem of obesity: health implications of overweight and obesity in the United States. Ann. Intern. Med. 1995; 103: 983-988.
9. Pi-Sunyer F., Lafferrere B., Aronne L., Bray G. Obesity-a modern-day epidemic. J. Clin. Endocrinol. Metab. 1999; 84: 3-5.
10. Rywik S., Wa̧growska H., Piotrowski W. Epidemia otylości jako czynnik ryzyka chorób uktadu kra̧żzenia. Pol. Tyg. Lek. 1995; 50 (supl. I): 63-67.
11. Report of a WHO Consultation on Obesity. Preventing and Managing the Global Epidemic. Division of noncomunicable Diseases. World Health Organization. Geneva 3-5 June 1997. WHO/NUT/NCD 1998.
12. Kern P., Saghizadeh M., Ong J., Bosch R., Deem R., Simsolo R. The expression of tumor necrosis factor in human adipose tissue. Regulation of obesity, weight loss, and relationship to lipoprotein lipase. J. Clin. Invest. 1996; 97: 1111-1116.
13. Hotamisligil G., Arner P., Caro J., Atkinson R., Spiegelman B. Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 1995; 95: 2409-2415.
14. Saghizadeh M., Ong J., Garvey W., Henry R., Kern P. The expression of TNF-alpha by human muscle. Rclationship to insulin resistancc. J. Clin. Invest. 1996: 97: 1111-1116.
15. Kern P., Ranganathan S., La C., Wood I., Ranganathan G. Adiposo tissue tumor necrosis factor and interleukin-6-expression in human obesity and insulin resistance. Am. J. Physiol. 2001: 28O: 745-751.
16. Koj A. Biologiczne funkcje bialek ostrej fazy. Diagn. Lab. 1987: 23: 191-208.
17. Mendall M.A. C-reactive protein and its relation to cardiovascular risk factor: a population based cross sectional study. BMJ 1996: 312: 1061-1065.
18. Ross R., Glomset J. Atherosclerosis and the arterial smooth muscle cell: proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis. Science 1973; 180: 1332.
19. Toss H.; Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibronegen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997; 96: 4204.
20. Festa A., D'Agostino R., Haward G., Mykannen L., Tracy R., Haffner S. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 1: 42-47.
21. Yudkin J., Kumari M., Humphrsier S., Mohamed-Ali V. Inflammation, obesity, strcss ¿red coronary heart: is interleukin-6 the link? Arherosclerosis 2000; 2: 209-214.
22. Uysal K., Wiesbrock S., Marino M. Hotamisligil G. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 1997; 389: 610-614.
23. Stephens J.M., Pekala P.H. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J. Biol. Chem. 1991; 266: 21839-21845.
24. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha and obesity-induced insulin resistance. Science 1996; 271: 665-668.
25. Hotamisligil G., Murray D., Choy L., Spiegelman B. Tumor necrosis factor-inhibits signaling from the insulin receptor. Proc. Natl. Acad. USA 1994; 91: 4854-4858.
26. Bonadonna R.C., DeFronzo R.A. Glucose metabolism in obesity and type II diabetes. J.B. Lippincott, 1992: 474-501.
27. Ferrannini E. Insulin resistance in essential hypertension. N. Engl. J. Med. 1987; 317: 350-357.
28. Van der Poll T., Romijnm A., Endert E., Borin J.J.J., Buller H.R., Sauerwein H.P. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am. J. Physiol. 1991; 261: 247-465.
29. Dandona P., Weinstock R., Thusu K., Abdelrahman E., Ijada A., Wadden T. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J. Clin. Endocrinol. Metab. 1998; 83: 2907-2910.